KATZ MARK STEPHEN purchased $100K of RYAN

KATZ MARK STEPHEN (EVP & General Counsel) purchased 3,215 shares of RYAN SPECIALTY HOLDINGS, INC. (RYAN) at $31.07 on 2026-06-03.

Original reporting
SEC EDGAR · KATZ MARK STEPHEN
Published Jun 4, 2026, 12:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 4, 2026, 12:34 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RYAN
Bullish
medium confidence
Mentioned
$RYAN
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RYANBullishLow
01

Why it matters

The disclosure provides a fresh datapoint on insider ownership but does not include any new corporate guidance, contract, litigation, or financial results.

02

Market read

Traders may treat this as a small sentiment input, but it is unlikely to drive a sustained repricing without additional catalysts.

03

What to watch

No 10b5-1 plan is cited, but the transaction still lacks context on motivation, timing constraints, or whether other insiders are buying/selling.

Relevance 5/10Novelty 6/10Timing: Filed today; purchase executed 2026-06-03 (use for positioning around the next few sessions).

Background

The article is an SEC Form 4 insider transaction disclosure for RYAN Specialty Holdings, Inc.

Company-level read

Ticker impact

$RYANBullishMedium confidence
Context

RYAN disclosed an officer (EVP & General Counsel) open-market purchase of 3,215 shares on 2026-06-03 via SEC Form 4.

Expected impact

Likely limited near-term impact; any effect is typically short-lived unless followed by additional insider activity or fundamental catalysts.

Evidence & confidence

The filing is an ownership-change disclosure (Form 4) with no stated corporate event; insider buys are informative but not typically market-moving on their own.

Market effects

No direct sector read-through; this is company-specific insider activity.

None.

None.

Counterpoint

Insider open-market buys can be routine (compensation, diversification, or pre-planned behavior) and may not reflect new fundamentals.

Key entities

  • RYAN Specialty Holdings, Inc.

    Subject of the SEC Form 4 insider transaction; officer purchased shares on 2026-06-03.

  • Katz Mark Stephen

    EVP & General Counsel who reported the open-market purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RYANMed

Ryan Specialty Holdings Inc (RYAN) (Q3 2026) Earnings Call Highlights: Revenue Growth

Ryan Specialty Holdings (RYAN) reported Q3 2026 revenue growth slowing to 4% from 15% YoY, with adjusted EBITDAC margin down 30 bps to 30.9%. The company cited market challenges, including property pricing declines and increased competition. Management expects continued pressure in Q4 2026 and 2027, with modest margin expansion anticipated. They also discussed growth opportunities in reinsurance and AI-related risks, and potential M&A activity in 2027.

Med

Ryan Specialty grows revenue as property softening squeezes E&S returns

Ryan Specialty reported a 4.7% revenue increase to $790M in Q3 2026, driven by casualty lines, while property revenue declined. Underwriting management grew 5.4%, expanding its share of total revenue. Expenses rose 9.9%, outpacing revenue growth. The company maintained its full-year guidance for mid-single-digit organic revenue growth and reported a 3.8% increase in adjusted EBITDAC to $244.4M.